Zennova Pharmaceuticals Group announced that it has received nearly CNY 100 million in a round of funding on July 21, 2023. The transaction included participation from new investor Hengbao Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.79 CNY | +0.52% | -3.82% | -24.61% |
04-30 | Hengbao Co.,Ltd. Proposes Final Dividend for 2023 | CI |
04-29 | Hengbao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.61% | 563M | |
+114.99% | 2,619B | |
+47.05% | 700B | |
+26.12% | 652B | |
+12.86% | 269B | |
+45.45% | 235B | |
+16.85% | 181B | |
+51.73% | 143B | |
-38.87% | 131B | |
+52.56% | 119B |
- Stock Market
- Equities
- 002104 Stock
- News Hengbao Co.,Ltd.
- Zennova Pharmaceuticals Group announced that it has received CNY 100 million in funding from Hengbao Co.,Ltd.